Gts Securities LLC Ginkgo Bioworks Holdings, Inc. Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $2,156 - $8,932	-7,700 Reduced 12.75%	52,700 $17,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $70,490 - $111,055	-66,500 Reduced 52.4%	60,400 $70,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $5,796 - $8,234	-4,600 Reduced 3.5%	126,900 $214,000
Q3 2023 Nov 15, 2023	BUY	$1.61 - $2.54 $211,715 - $334,010	131,500 New	131,500 $238,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.